2 enrolling by invitation. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Enrolling by invitation 2 |
Follow PSP - Progressive Supranuclear Palsy: new trials by email Literature Review of PSP - Progressive Supranuclear Palsy trials Research Report on PSP - Progressive Supranuclear Palsy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31 LM11A-31, Matching Placebo - PSP - Progressive Supranuclear Palsy | Phase 2 | Enrolling by invitation | Adam Boxer | 147 | 2026-07-29 | 2026-08-12 |
| The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1 AADvac1, Matching Placebo - PSP - Progressive Supranuclear Palsy | Phase 2 | Enrolling by invitation | Adam Boxer | 146 | 2026-07-29 | 2026-08-13 |
Frontotemporal Dementia (2) · Supranuclear Palsy, Progressive (2)
Basal Ganglia Diseases (2) · Brain Diseases (2) · Central Nervous System Diseases (2) · Cranial Nerve Diseases (2) · Dementia (2) · Eye Diseases (2) · Frontotemporal Lobar Degeneration (2) · Mental Disorders (2) · Metabolic Diseases (2) · Movement Disorders (2) · Nervous System Diseases (2) · Neurocognitive Disorders (2) · Neurodegenerative Diseases (2) · Neurologic Manifestations (2) · Nutritional and Metabolic Diseases (2)
Adam Boxer (2)
United States (2)
Adam Boxer, MD, PhD (2) · Anne-Marie Wills, MD (2) · Irene Litvan, MD (2) · Julio Rojas-Martinez, MD, PhD (2)
R01AG085029 (2)